Mark S Blumenkranz Net Worth & Insider Trades
Mark S Blumenkranz - Director, Avalanche Biotechnologies, Inc
What is Mark S Blumenkranz's Net Worth?
The current estimated net worth of Avalanche Biotechnologies, Inc's Director, Mark S Blumenkranz, is estimated to be about $11.04M . Mark S Blumenkranz owns about 533,520 units of Avalanche Biotechnologies, Inc common stock. Recently at Avalanche Biotechnologies, Inc, Mark S Blumenkranz has sold an estimated value of $1.1M worth.
What is Mark S Blumenkranz's Past Insider Trading?
Mark S Blumenkranz's largest sale order was 23,100 units , worth over $828.28K on June 11, 2015. In total, Mark S Blumenkranz has made about 3 transactions recently at Avalanche Biotechnologies, Inc. Mark S Blumenkranz usually trades in June, with the busiest year in 2015. The most recent transaction was a sale order of 1,900 units , worth over $75.94K on June 15, 2015.
Mark S Blumenkranz
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Mark S Blumenkranz's' Mailing Address?
- Mailing address is C/o 1life Healthcare, Inc. One Embarcadero Center, Suite 1900 San Francisco CA 94111 CA
Avalanche Biotechnologies, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|---|
| Alfred F. Kelly, Jr. | 2020 | $1,550,076 | - | $17,026,616 | $4,562,500 | - | - | $ | $26,364,928 |
| Alfred F. Kelly, Jr. | 2019 | $1,400,059 | - | $14,246,423 | $4,312,489 | - | - | $36,800 | $24,265,771 |
| Alfred F. Kelly, Jr. | 2018 | $1,300,038 | - | $8,693,984 | $3,500,008 | - | - | $26,416 | $19,493,946 |
| Vasant M. Prabhu | 2020 | $1,100,050 | - | $8,039,757 | $2,124,987 | $1,209 | $1,209 | $23,850 | $13,049,853 |
| Vasant M. Prabhu | 2019 | $1,000,040 | - | $6,493,501 | $1,625,005 | $1,372 | $1,372 | $26,800 | $11,586,718 |
| Vasant M. Prabhu | 2018 | $1,000,038 | - | $5,848,193 | $1,999,994 | $1,215 | $1,215 | $16,500 | $12,569,940 |
| Ryan McInerney | 2020 | $1,100,050 | - | $9,439,901 | $2,624,994 | $3,227 | $3,227 | $27,100 | $14,955,272 |
| Ryan McInerney | 2019 | $900,047 | - | $7,133,141 | $1,825,008 | $3,600 | $3,600 | $30,621 | $12,088,417 |
| Ryan McInerney | 2018 | $900,035 | - | $6,777,537 | $2,250,003 | $3,351 | $3,351 | $21,500 | $13,286,026 |
| Rajat Taneja | 2020 | $1,100,050 | - | $8,939,651 | $2,500,007 | $1,743 | $1,743 | $20,850 | $14,322,301 |
| Rajat Taneja | 2019 | $900,047 | - | $6,977,836 | $1,712,503 | $1,969 | $1,969 | $22,215 | $11,810,570 |
| Rajat Taneja | 2018 | $900,035 | - | $6,803,356 | $2,125,007 | $1,769 | $1,769 | $17,750 | $13,154,517 |
| Paul Fabara | 2020 | $750,035 | - | $9,128,814 | $3,381,227 | - | - | $8,899,802 | $23,059,878 |
| No matching records found | |||||||||
Source: https://www.sec.gov/Archives/edgar/data/1403161/000119312520309539/d75661ddef14a.htm
What are Avalanche Biotechnologies, Inc's Past Insider Trades?
Avalanche Biotechnologies, Inc's most recent insider trade came on June 17, 2015 by Mehdi Gasmi who sold 500 units worth $19.93K . In the last month, insiders at Avalanche Biotechnologies, Inc have sold an estimated value of $4.83M and bought an estimated value of $20.05K worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Mark S Blumenkranz, Director, Paul Wachter, Director, and Mehdi Gasmi, SVPPharmaceutical Development .
Avalanche Biotechnologies, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||